Oridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cells

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1303-1307

  Ji, Zhe ^a,b   Tang, Qingjiu ^a   Zhang, Jinsong ^a   Yang, Yan ^a   Liu, Yanfang ^a   Pan, Yingjie ^c  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI OCEAN UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Oridonin

Indexed keywords

CASPASE 3; ORIDONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL STRUCTURE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; RABDOSIA;

EID: 80052754693     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.408     Document Type: Article

References (26)

1. Fuji K, Node M, Sai M, Fujita E, Takeda S and Unemi N: Terpenoids. LIII. Antitumor activity of trichorabdals and related compounds. Chem Pharm Bull (Tokyo) 37: 1472-1476, 1989.
2. Osawa K, Yasuda H, Maruyama T, Morita H, Takeya K and Itokawa H: Antibacterial trichorabdal diterpenes from Rabdosia trichocarpa. Phytochemistry 36: 1287-1291, 1994.
3. Zhang Y, Wang J, Lou LG, Zhang TM and Hou JW: Scavenging effect of oridonin on active oxygen free radicals. Henan Medical Research 8: 100-104, 1999.
4. Ikezoe T, Chen SS, Tong XJ, Heber D, Taguchi H and Koeffler HP: Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol 23: 1187-1193, 2003.
5. Liu YQ, You S, Tashiro S, Onodera S and Ikejima T: Roles of Ras and extracellular signal-regulated kinase-dependent IκBα degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells. Int Immunopharmacol 6: 260-268, 2006.
6. Kosty MP: PC-SPES: hope or hype? J Clin Oncol 22: 3657-3659, 2004.
7. Darzynkiewicz Z, Traganos F, Wu JM and Chen S: Chinese herbal mixture PC SPES in treatment of prostate cancer (Review). Int J Oncol 17: 729-736, 2000.
8. de la Taille A, Hayek OR, Burchardt M, Burchardt T and Katz AE: Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports. J Altern Complement Med 6: 449-451, 2000.
9. Sartippour MR, Seeram NP, Heber D, et al: Rabdosia rubescens inhibits breast cancer growth and angiogenesis. Int J Oncol 26: 121-127, 2005.
10. Fujita E, Nagao Y, Node M, Kaneko K, Nakazawa S and Kuroda H: Antitumor activity of the Isodon diterpenoids: structural requirements for the activity. Experientia 32: 203-206, 1976.
11. Beauparlant P and Shore GC: Therapeutic activation of caspases in cancer: a question of selectivity. Curr Opin Drug Discov Devel 6: 179-187, 2003.
12. Thorburn A: Death receptor-induced cell killing. Cell Signal 16: 139-144, 2004.
13. Qi SN, Yoshida A, Wang ZR and Ueda T: GP7 can induce apoptotic DNA fragmentation of human leukemia cells through caspase-3-dependent and-independent pathways. Int J Mol Med 13: 163-167, 2004.
14. Zhang JF, Liu JJ, Liu PQ, Lin DJ, Li XD and Chen GH: Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells. Hepatol Res 35: 104-110, 2006.
15. Subramaniam V, Vincent IR and Jothy S: Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells. Exp Mol Pathol 79: 187-193, 2005.
16. Moore MA and Tsuda H: Chronically elevated proliferation as a risk factor for neoplasia. Eur J Cancer Prev 7: 353-385, 1998.
17. Mori H, Sugie S, Yoshimi N, Hara A and Tanaka T: Control of cell proliferation in cancer prevention. Mutat Res 428: 291-298, 1999.
18. Martin SJ, Reutelingsperger CP, McGahon AJ, et al: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182: 1545-1556, 1995.
19. Towle MJ, Salvato KA, Budrow J, et al: In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res 61: 1013-1021, 2001.
20. Hood KA, West LM, Rouwe B, et al: Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity. Cancer Res 62: 3356-3360, 2002.
21. Follstad BD, Wang DI and Stephanopoulos G: Mitochondrial membrane potential differentiates cells resistant to apoptosis in hybridoma cultures. Eur J Biochem 267: 6534-6540, 2000.
22. Donepudi M and Grutter MG: Structure and zymogen activation of caspases. Biophys Chem 101-102: 145-153, 2002.
23. Denault JB and Salvesen GS: Caspases: keys in the ignition of cell death. Chem Rev 102: 4489-4500, 2002.
24. Boatright KM and Salvesen GS: Caspase activation. Biochem Soc Symp: 233-242, 2003.
25. Philchenkov AA: Caspases as regulators of apoptosis and other cell functions. Biochemistry (Mosc) 68: 365-376, 2003.
26. Huether A, Hopfner M, Sutter AP, Schuppan D and Scherubl H: Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics. J Hepatol 43: 661-669, 2005.